Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

New ROR-gamma receptor modulators patented by Roche and Genentech

Oct. 10, 2014

Sanofi divulges new SGK1 inhibitors

Oct. 8, 2014

Medac Pharma launches Rasuvo in U.S.

Oct. 7, 2014

Lilly to discontinue development of tabalumab

Oct. 3, 2014

SignaBlok receives NIH grant to develop TREM-1 inhibitors for rheumatoid arthritis

Oct. 1, 2014

Identification of SARMs that can be administered transdermally

Sep. 26, 2014

Endpoints met in phase III studies of secukinumab for psoriatic arthritis

Sep. 25, 2014

Epirus reports 58-week follow-up data for infliximab biosimilar

Sep. 25, 2014

Transparency Life Sciences to conduct trial of Kiacta in sarcoidosis

Sep. 23, 2014

FDA places clinical hold on phase IIb study of Flexion's FX-006 for knee osteoarthritis

Sep. 18, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...